The Seattle Storm’s Gabby Williams has walked away from women’s pro basketball after pointing out that even rookie star Caitlin Clark is not paid well in the WNBA.
Williams, 28, claims that she quit the WNBA to play for Fenerbahçe S.K. in Turkey because the U.S. league was too cheap, and she used Clark as her prime example, the Daily Mail reported.
She said that the league claims that players can make “up to” $700,000 a year in salary, but Williams insists that no player, including Clark, makes that much in salary alone.
Williams also said she was promised big money when she was drafted into the Chicago Sky in 2018, but it never happened. “We were promised team marketing agreements and league marketing agreements, but they’ve fallen quite short,” she said.
“So it’s still not enough for us international players to want to stay here. And that’s a choice of the players,” the player added.
“If I make a choice to make more money, whatever, and then teams are mad that I don’t come back, but that’s how it is,” she said. […]
— Read More: www.breitbart.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
